Breaking News
December 10, 2018 - A Tale of Two Labels
December 10, 2018 - Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
December 10, 2018 - A 14-year-old explains what it’s like to get a new heart
December 10, 2018 - Team Players Honored with 2018 Baton Awards
December 10, 2018 - Global report highlights how the changing world is affecting children’s physical activity levels
December 10, 2018 - Genes play a role in physical activity and sleep
December 10, 2018 - DDT in Alaskan fish shown to increase risk of cancer
December 10, 2018 - Laws to curb use of cell phones have greatly reduced fatalities for motorcyclists
December 10, 2018 - Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia
December 10, 2018 - University of Maryland doctors treat first breast cancer patients with GammaPod radiotherapy
December 10, 2018 - The heartbeat seat: Demoing new well-being technologies in a car
December 10, 2018 - Leading Cancer Researcher to Direct Herbert Irving Comprehensive Cancer Center
December 10, 2018 - Study compares pain-related diagnoses in First Nations and non-First Nations children, youth
December 10, 2018 - Scientists find answers to how cancer spreads
December 10, 2018 - Study explores why older people read more slowly
December 10, 2018 - Smart life-collar could save lives of young children
December 10, 2018 - Asbestos found in most NHS hospitals finds BBC inquiry
December 10, 2018 - Researchers use new technique to probe hydrogen bonds
December 10, 2018 - Music improves social communication in autistic children
December 10, 2018 - Some Brain Tumors May Respond to Immunotherapy, New Study Suggests
December 10, 2018 - Banning junk food ads to combat childhood obesity
December 10, 2018 - Skin Autofluorescence Predicts T2DM, Heart Disease, Mortality
December 10, 2018 - Largest autism sequencing study to date yields 102 genes associated with ASD
December 10, 2018 - Statins associated with low risk of side effects
December 10, 2018 - Episodic memory tests help in predicting brain atrophy and Alzheimer’s disease
December 10, 2018 - Study explores how schools address adolescent self-harming practices
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - HPV type 16 or 18 associated with cervical cancer risk in young women
December 10, 2018 - Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
Blockade at the receptor

Blockade at the receptor

image_pdfDownload PDFimage_print
Polymorphic nuclear leukocytes infected with Chlamydia (blue). Credit: Karthika Rajeeve

When chlamydia attacks the human body, the immune system activates. But the bacteria are adapted to defend themselves. Scientists from Würzburg have deciphered new details of their strategy.

Chlamydia trachomatis is a common sexually transmitted disease. More than 131 million people are infected with this bacterium worldwide. If detected at an early stage and treated with antibiotics, the infection can be halted. However, chlamydia often develops without symptoms, and in many cases goes unnoticed. This promotes the spread of the pathogen and increases the chance for secondary infections, e.g. with HIV or Neisseria gonorrhoeae, the causative agent of gonorrhoea.

How does Chlamydia trachomatis avoid the attack of the human immune system and thereby also prevent the typical symptoms of an infection? An answer to this question is provided by a new study of scientist of the Julius-Maximilians-Universität Würzburg (JMU). Dr. Karthika Rajeeve and Professor Thomas Rudel, head of the Chair of Microbiology, showed that the bacterium actively deactivates special cells of the immune system, so-called polymorphic nuclear leukocytes (PMNs), and thereby secures its own survival. The results of their work are presented in the current issue of the journal Nature Microbiology.

The struggle between pathogen and immune system follows a defined process in humans: Special leukocytes of the innate immune response become active following an infection. They can take up pathogenic organisms and digest them, and they also secrete special substances that damage bacteria. Leukocytes also form structures called neutrophil extracellular traps that bind microorganisms and kill them. However, many pathogens have developed mechanisms in the course of evolution to destroy these traps, as Chlamydia trachomatis does.

“From previous studies, it was already known that chlamydia is disturbing single steps of the innate immune signal pathways. But the exact mechanism was unknown until now,” Thomas Rudel explains. Now, the scientists of the JMU have discovered vital details of these disturbances: “We could prove that free chlamydia even in direct interaction do not activate PMNs. As soon as PMNs attack chlamydia, these cells are paralyzed and do not react to the activation by different stimuli,” Rudel says.

The researchers have identified two receptors and a special protein as main players in this battle between bacteria and immune system—the formyl peptide receptor type 1 (FPR1) and type 2 (FPR2) as well as the chlamydial protease like activating factor (CPAF). Both receptors constitute the “antennae” of the immune cells. When they recognize a potential invader, they transmit a signal to the interior of the cell and in this way initiate the immune response. Whereas FPR1 recognizes only particular peptides, FPR2 can bind broader spectrum of proteins, peptides and lipids.

Rudel and his team have now revealed how chlamydia prevent the activation of this process: “We have identified CPAF as the agent which blocks the innate immune response,” Rudel says. In their experiments the scientists could show that chlamydia that could not produce CPAF were identified and efficiently killed by immune cells without problem.

Moreover, they identified formyl peptide receptor 2 as a target of CPAF. ” FPR2 is cleaved by CPAF and removed from the surface of the immune cells,” Rudel says. In contrast, the related FPR1 remains intact in infected cells and mediates its signals. “However, these FPR1-signal pathways seem not to be activated in infected immune cells,” Karthika Rajeeve says.

The fact that CPAF plays a crucial role in the process of infection outside of the cell holds the chance for new drugs against the pathogen, according to the scientists. A substance that blocks CPAF could be an appropriate therapeutic agent against chlamydia infections. However, this requires a deeper understanding of the strategies chlamydia employs to paralyze the innate immune system.


Explore further:
Newly designed molecule blocks chlamydia bacteria

More information:
Karthika Rajeeve et al, Chlamydia trachomatis paralyses neutrophils to evade the host innate immune response, Nature Microbiology (2018). DOI: 10.1038/s41564-018-0182-y

Journal reference:
Nature Microbiology

Provided by:
University of Würzburg

Tagged with:

About author

Related Articles